Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury (SyNAPSe)

This study has been completed.
Sponsor:
Collaborators:
PRA Health Sciences
INC Research
Information provided by (Responsible Party):
BHR Pharma, LLC
ClinicalTrials.gov Identifier:
NCT01143064
First received: June 10, 2010
Last updated: June 11, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 11, 2014
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):